“On 19 December 2019, the Court of Appeal issued its judgment in Teva v. Gilead concerning the supplementary protection certificate relating to the antiviral combination sold under the name Truvada ®. Gilead’s appeal from Arnold J was dismissed and the court confirmed the invalidity of the SPC on the ground of non-compliance with Article 3(a) of the Regulation. Daniel Alexander QC and James Whyte at 8 New Square acted in the case which, at an earlier stage, involved one of the relatively rare full Grand Chamber hearings before the CJEU”.
+44(0)20 7405 4321
clerks@8newsquare.co.uk